Cannabis abuse with psychotic disorder with hallucinations
ICD-10 F12.151 is a billable code used to indicate a diagnosis of cannabis abuse with psychotic disorder with hallucinations.
Cannabis abuse with psychotic disorder with hallucinations refers to a condition where an individual exhibits a pattern of cannabis use that leads to significant impairment or distress, accompanied by psychotic symptoms such as hallucinations. This diagnosis is characterized by the presence of hallucinations, which can be auditory, visual, or tactile, occurring in the context of cannabis use. The psychotic disorder may manifest during periods of intoxication or withdrawal from cannabis, and it can significantly impact the individual's ability to function in daily life. The diagnosis requires careful assessment to differentiate between primary psychotic disorders and those induced by substance use. Treatment often involves a combination of psychotherapy, psychoeducation, and, in some cases, pharmacotherapy to manage psychotic symptoms. Long-term management may also include substance use disorder treatment programs to address the underlying cannabis abuse.
Detailed patient history, including substance use history and mental health evaluations.
Patients presenting with acute psychosis following cannabis use, or those with chronic cannabis use and worsening psychiatric symptoms.
Consideration of co-occurring disorders and the need for a multidisciplinary approach to treatment.
Comprehensive assessment of substance use patterns and psychosocial factors.
Patients in withdrawal experiencing psychotic symptoms or those in recovery with a history of cannabis abuse.
Integration of addiction treatment strategies with psychiatric care.
Used for follow-up visits for patients diagnosed with cannabis abuse and psychotic disorder.
Documentation must include assessment of symptoms, treatment plan, and progress notes.
Psychiatrists may need to provide detailed notes on the patient's mental status and substance use history.
F12.151 includes the presence of hallucinations as part of the psychotic disorder, while F12.150 does not. Accurate documentation of symptoms is crucial for correct coding.
